Neoplastic–Stromal Cell Cross-talk Regulates Matrisome Expression in Pancreatic Cancer
- 1 December 2020
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Research
- Vol. 18 (12) , 1889-1902
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is characterized by a highly desmoplastic reaction, warranting intense cancer–stroma communication. In this study, we interrogated the contribution of the BET family of chromatin adaptors to the cross-talk between PDAC cells and the tumor stroma. Short-term treatment of orthotopic xenograft tumors with CPI203, a small-molecule inhibitor of BET proteins, resulted in broad changes in the expression of genes encoding components of the extracellular matrix (matrisome) in both cancer and stromal cells. Remarkably, more than half of matrisome genes were expressed by cancer cells. In vitro cocultures of PDAC cells and cancer-associated fibroblasts (CAF) demonstrated that matrisome expression was regulated by BET-dependent cancer–CAF cross-talk. Disrupting this cross-talk in vivo resulted in diminished growth of orthotopic patient-derived xenograft tumors, reduced proliferation of cancer cells, and changes in collagen structure consistent with that of patients who experienced better survival. Examination of matrisome gene expression in publicly available data sets of 573 PDAC tumors identified a 65-gene signature that was able to distinguish long- and short-term PDAC survivors. Importantly, the expression of genes predictive of short-term survival was diminished in the cancer cells of orthotopic xenograft tumors of mice treated with CPI203. Taken together, these results demonstrate that inhibiting the activity BET proteins results in transcriptional and structural differences in the matrisome are associated with better patient survival. Implications: These studies highlight the biological relevance of the matrisome program in PDAC and suggest targeting of epigenetically driven tumor–stroma cross-talk as a potential therapeutic avenue.Keywords
Funding Information
- German Research Foundation (HO 5737/1-1)
- German Cancer Aid foundation (70112880)
This publication has 47 references indexed in Scilit:
- Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretionNature, 2012
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular MatricesMolecular & Cellular Proteomics, 2012
- Stromal biology and therapy in pancreatic cancerGut, 2010
- Pancreatic stellate cells produce acetylcholine and may play a role in pancreatic exocrine secretionProceedings of the National Academy of Sciences, 2010
- Osteopontin: Role in extracellular matrix deposition and myocardial remodeling post-MIJournal of Molecular and Cellular Cardiology, 2010
- Extracellular Matrix–Mediated Membrane-Type 1 Matrix Metalloproteinase Expression in Pancreatic Ductal Cells Is Regulated by Transforming Growth Factor-β1Cancer Research, 2006
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005
- Desmoplastic Reaction in Pancreatic CancerPancreas, 2004
- Smad4/DPC4-dependent Regulation of Biglycan Gene Expression by Transforming Growth Factor-β in Pancreatic Tumor CellsJournal of Biological Chemistry, 2002
- Periacinar stellate shaped cells in rat pancreas: identification, isolation, and cultureGut, 1998